HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noninvasive imaging of tumor hypoxia after nanoparticle-mediated tumor vascular disruption.

Abstract
We have previously demonstrated that endothelial targeting of gold nanoparticles followed by external beam irradiation can cause specific tumor vascular disruption in mouse models of cancer. The induced vascular damage may lead to changes in tumor physiology, including tumor hypoxia, thereby compromising future therapeutic interventions. In this study, we investigate the dynamic changes in tumor hypoxia mediated by targeted gold nanoparticles and clinical radiation therapy (RT). By using noninvasive whole-body fluorescence imaging, tumor hypoxia was measured at baseline, on day 2 and day 13, post-tumor vascular disruption. A 2.5-fold increase (P<0.05) in tumor hypoxia was measured two days after combined therapy, resolving by day 13. In addition, the combination of vascular-targeted gold nanoparticles and radiation therapy resulted in a significant (P<0.05) suppression of tumor growth. This is the first study to demonstrate the tumor hypoxic physiological response and recovery after delivery of vascular-targeted gold nanoparticles followed by clinical radiation therapy in a human non-small cell lung cancer athymic Foxn1nu mouse model.
AuthorsNeeda A Virani, Olivia J Kelada, Sijumon Kunjachan, Alexandre Detappe, Jihun Kwon, Jennifer Hayashi, Ana Vazquez-Pagan, Douglas E Biancur, Thomas Ireland, Rajiv Kumar, Srinivas Sridhar, G Mike Makrigiorgos, Ross I Berbeco
JournalPloS one (PLoS One) Vol. 15 Issue 7 Pg. e0236245 ( 2020) ISSN: 1932-6203 [Electronic] United States
PMID32706818 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Gold
Topics
  • A549 Cells
  • Animals
  • Carcinoma, Non-Small-Cell Lung (blood supply, drug therapy, radiotherapy)
  • Gold (therapeutic use)
  • Humans
  • Lung Neoplasms (blood supply, drug therapy, radiotherapy)
  • Metal Nanoparticles (therapeutic use)
  • Mice
  • Mice, Nude
  • Optical Imaging (methods)
  • Tumor Hypoxia (drug effects, radiation effects)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: